Emovis GmbH

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic spontaneous urticaria1 trial
• Depression1 trial
• Heart failure1 trial
• Obesity1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Amgen Inc.1 trial
• Dr. Willmar Schwabe GmbH & Co. KG1 trial
• Evommune Inc.1 trial

Running trials

• Active, not recruiting

  Silexan® in mild to moderate major depressive disorder

  2025-521744-37-00· Phase 3· Dr. Willmar Schwabe GmbH & Co. KG· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)

  2024-516654-22-00· Phase 3· Amgen Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  Dose-ranging study evaluating the efficacy and safety of EVO756 in adults with Chronic Spontaneous Urticaria.

  2024-518786-10-01· Phase 2· Evommune Inc.· Source